ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

EXPLORING THE DEVELOPMENT OF DENDRITIC CELL-BASED CANCER VACCINES WITH A FOCUS ON CANCER RESEARCH

Journal: International Journal of Advanced Research (Vol.11, No. 09)

Publication Date:

Authors : ; ;

Page : 1248-1256

Keywords : Cancer Vaccine Dendritic Cell APC Tumour Immunity;

Source : Downloadexternal Find it from : Google Scholarexternal

Abstract

The fundamental premise behind clinical approaches for dendritic cell mediated immunization in cancer is that the limiting defect in natural antitumor immunity is at the level of antigen presentation. In contrast to vaccines for the prevention of infections, cancer vaccines are administered in a therapeutic mode, to eradicate antigen-bearing tumor cells already present in the host. Over decades, the identification of antigens that can serve as targets for immune effectors have resulted in a profusion of strategies for activating tumor antigen-specific immune responses. Therapeutic vaccines, unlike prophylactic vaccines for the prevention of infections, all share some basic attributes, the presence of target antigens, and a method for delivering the antigen into the antigen-presentation machinery in conjunction with other molecules required to provide T- and/or B-cell activation.

Last modified: 2023-11-04 20:00:16